News

Projected Growth of Mice Model Market to Reach $2.74 Billion

Projected Growth of Mice Model Market to Reach $2.74 Billion

The Expanding Mice Model Market

The Mice Model Market is poised for significant growth, projected to reach a whopping US$2.74 billion by the year 2030. With a compound annual growth rate (CAGR) of 10.0%, this market has seen increasing importance within the biomedical research community. The rising adoption of mice models in preclinical studies is contributing to this impressive growth.

Driving Forces Behind Market Growth

Several factors are fueling the growth of the Mice Model Market. The genetic and physiological versatility of these models makes them invaluable in various research fields. With the rise in demand for clinical trials involving mice, along with a surge in personalized medicine, especially in oncology, the market is expected to expand further. The advancements in genetic engineering, particularly with technologies such as CRISPR, are further accelerating this growth.

The Role of CRISPR Technology

CRISPR technology has reshaped the landscape of biomedical research. Its utilization extends to developing disease-specific models and enhancing research capabilities. By enabling precise genome editing, CRISPR allows for the rapid generation of animal models that reflect human diseases more accurately. This advancement not only streamlines research processes but also enhances the reliability of findings.

Market Segmentation

The Mice Model Market is categorized by model types, which include inbred, genetically engineered, hybrid/congenic, and outbred mice. Inbred mice, known for their genetically identical strains, account for a significant portion of the market due to their reliability and reproducibility across studies.

Classifications by Technology

In terms of technology, the leading segment is CRISPR/Cas9, celebrated for its efficiency in genome editing. Its ability to facilitate targeted DNA modifications makes it an important tool for researchers who are exploring complex biological questions. Researchers can rely on this technology to conduct high-throughput genetic screenings, greatly improving research output.

Geographic Insights

From a geographical perspective, North America dominates the Mice Model Market due to its established infrastructure and active participation in biomedical research. The U.S. stands out as a key contributor, housing numerous contract research organizations and academic centers that specialize in mice models.

Key Players in the Market

Numerous players are instrumental in shaping the Mice Model Market. Charles River Laboratories, a crucial name in this sector, offers over 150 specialized strains to cater to various research needs. Their commitment to high-quality standards and rapid delivery enhances their reputation among clients.

Focus on Research and Development

Organizations like The Jackson Laboratory play a vital role in advancing the field, with a strong focus on developing targeted mutant mouse models. Inotiv is also notable for its diverse portfolio of genetically engineered strains, showing their dedication to expanding research capabilities through acquisitions and strategic growth.

The Future of Mice Models in Research

As technology continues to evolve, the Mice Model Market is expected to benefit from ongoing advancements in genetic engineering and biotechnologies. The increasing reliance on these models in drug development and therapeutic research underscores their importance in future biomedical endeavors.

Frequently Asked Questions

What is the projected value of the Mice Model Market by 2030?

The Mice Model Market is projected to reach US$2.74 billion by 2030.

What technology is driving the growth of the Mice Model Market?

CRISPR technology is significantly driving growth due to its efficiency in genome editing.

Which segment leads the Mice Model Market in terms of model type?

Inbred mice currently hold the largest market share among model types.

What geographical region dominates the Mice Model Market?

North America is the leading region in the Mice Model Market, driven by established research infrastructure.

Who are the key players in the Mice Model Market?

Key players include Charles River Laboratories, The Jackson Laboratory, and Inotiv, among others.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Chemours Faces Class Action Over Fraud Allegations

Updated Category News Views 206

Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 112

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 146

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 63

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
Lunit, Summit Tackle Tumor Analysis with AI Platform

Updated Category News Views 212

Amid whispers of AI revolutionizing every industry, let's zero in on its latest pit stop—oncology R&D. Lunit, shaking hands with Summit Therapeutics, plans to bring artificial intelligence into the tumor microenvironment analysis game, thanks to the Lunit SCOPE IO platform. This isn't just another lab experiment; it's a step towards redefining how we understand cancer's...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 66

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 35

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 46

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 27

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 89

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading

Top 5 Most Recently Viewed Articles

Fresh Del Monte's Sustainability Report Shows Significant Progress

Updated Category News Views 200

Fresh Del Monte's 2023 Sustainability Goals Fresh Del Monte Produce Inc. (NYSE: FDP), a prominent player in the global fruit and vegetable market, has released its sustainability report for the year, highlighting a remarkable journey toward environmental stewardship. This report showcases the substantial progress Fresh Del Monte has made in its sustainability initiatives,...

Continue Reading
MEXC Enhances User Security with New Compliance Measures

Updated Category News Views 118

MEXC Enhances User Security with New Compliance Measures MEXC, a prominent cryptocurrency exchange renowned for its global reach, has taken significant steps to enhance risk control and compliance protocols aimed at safeguarding users and ensuring the market's integrity. The organization remains committed to eradicating fraudulent behaviors and enhancing compliance...

Continue Reading
Market Insights: Asian Shares and Economic Influences

Updated Category News Views 154

Mixed Outcomes in Asian Markets Asian shares displayed a blend of positive and negative trends as markets reacted to the recent surge in U.S. stocks, which reached new peaks to end a successful trading week. U.S. futures reflected this mixed sentiment, while oil prices experienced an upward trend. Performance of Key Indices In Hong Kong, the Hang Seng index dropped 1.5%...

Continue Reading
Understanding Recent CPSC Recalls and Safety Measures

Updated Category News Views 280

Understanding Recent CPSC Recalls and Safety Measures The Consumer Product Safety Commission (CPSC) plays a crucial role in safeguarding the public from hazards associated with consumer products. Recently, several recalls have been announced to protect consumers from potential risks. These recalls, conducted in cooperation with various firms, aim to address safety...

Continue Reading
Significant Advancements in Lymphedema Treatment Using Flexitouch® Plus

Updated Category News Views 213

Groundbreaking Results from Flexitouch® Plus Study In an exciting development for medical technology, Tactile Systems Technology, Inc. (Nasdaq: TCMD) has presented remarkable findings from a recent late-breaking poster session at a prominent rehabilitation medicine conference. The data highlights the sustained clinical benefits of Flexitouch® Plus as a primary therapy...

Continue Reading